Fletcher Payne - 27 Jun 2022 Form 4 Insider Report for Aptose Biosciences Inc. (APTOF)

Role
SR VP & Chief Fin. Officer
Signature
/s/ Janet Clennett as attorney-in-fact for Fletcher Payne
Issuer symbol
APTOF
Transactions as of
27 Jun 2022
Net transactions value
$0
Form type
4
Filing time
28 Jun 2022, 16:16:43 UTC
Next filing
21 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APTO Common Stock Award $0 +1,000,000 $0.000000 1,000,000 27 Jun 2022 Common Stock 1,000,000 $0.8479 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as follows: 50% of the options vest on 6/27/2023; the remaining options will vest in equal annual installments on June 27, 2024, June 27, 2025, and June 27, 2026.